Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Mucositis × tempol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Prostate Cancer Recurrent 1 Ototoxicity 1 Neoplasm Metastasis 1 Mucositis 1 Glioblastoma 1

Interventions

Radiotherapy 4 angiotensin I (1-7) 3 Injections 3 Cisplatin 3 RRx-001 2 tempol 1 hydrated silica gel-based toothpaste 1 brilacidin 1 apraglutide 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Xylitol 1 Water 1 Therapeutics 1 Radiotherapy, Intensity-Modulated 1 Lidocaine 1 Fibroblast Growth Factor 7 1 Drug Therapy 1 Diphenhydramine 1 Betaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03480971 2024-11-20

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Matrix Biomed, Inc.

Phase 2 Recruiting

Ototoxicity, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡